Krilogy Financial’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Krilogy Financial's CRL Position: Q2 2023 in Review
Krilogy Financial sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 3,131 shares — an estimated $632K sold.
Krilogy Financial first reported a position in CRL in Q1 2019 and held it in 15 quarters. The position peaked at $1.49M in Q3 2021. 611 funds tracked by Wall St. Rank hold CRL as of Q2 2023.
- Krilogy Financial reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
- Krilogy Financial sold 3,131 Charles River Laboratories shares in Q2 2023, an estimated $632K.
- Krilogy Financial first reported a position in Charles River Laboratories in Q1 2019 and held it in 15 quarters.
- Krilogy Financial's Charles River Laboratories position peaked at $1.49M in Q3 2021.
- 611 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.
Based on Krilogy Financial's 13F filing for Q2 2023, filed 19 Jul 2023.